RSSDI Repository, Complications of Diabetes Demonstration RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

  • Home/
  • Article /
  • Efficacy and tolerability of exenatide monotherapy over 24 weeks in antidiabetic drug-naive patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, parallel-group study.

Efficacy and tolerability of exenatide monotherapy over 24 weeks in antidiabetic drug-naive patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, parallel-group study.

Add to Collection
2008 Aug Others Fist_Author_Year_PM

Full Author : ['Moretto, Thomas J', 'Milton, Denai R', 'Ridge, Terry D', 'Macconell, Leigh A', 'Okerson, Ted', 'Wolka, Anne M', 'Brodows, Robert G']
Journal Title : Clinical therapeutics
Chapter : Section3
Journal Year : 2008
Cited by : Not Available

BACKGROUND: Evaluation of exenatide monotherapy in patients with type 2 diabetes may be of clinical interest based on improvements in glycemic control and weight that have been reported with the use of exenatide in combination with oral antidiabetic agent.....

Keywords : ["randomize doubleblind placebocontrolle parallelgroup study", "antidiabetic drugnaive patient", "type diabetes", "exenatide monotherapy", "week", "tolerability", "efficacy"]